Prevention of diseases caused by Staphylococcus aureus using the peptide RIP

Peptides

Volumn 21, Issue 9, 2000, Pages 1301-1311

  Balaban, Naomi ^a   Collins, L Vincent ^b   Cullor, James S ^c   Hume, Emma B ^d   Medina Acosta, Enrique ^e   Vieira da Motta, Olney ^e   O'Callaghan, Richard ^d   Rossitto, Paul V ^c   Shirtliff, Mark E ^f   Serafim da Silveira, Leonardo ^e   Tarkowski, Andrej ^b   Torres, Jose V ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

^f University of Texas Medical Branch School of Medicine   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPTAPEPTIDE; PEPTIDE RIP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTHRITIS; CELLULITIS; CONTROLLED STUDY; COW; DISEASE COURSE; FEMALE; INJECTION; KERATITIS; MASTITIS; MOUSE; NONHUMAN; OSTEOMYELITIS; PATHOLOGY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE; SYMPTOM;

ANIMAL; ARTHRITIS, INFECTIOUS; CATTLE; FEMALE; KERATITIS; MASTITIS; MICE; MICE, INBRED STRAINS; OLIGOPEPTIDES; OSTEOMYELITIS; RABBITS; STAPHYLOCOCCAL INFECTIONS; SUPPORT, NON-U.S. GOV'T;

BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 0033783672     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00272-2     Document Type: Article

References (53)

1. The economic impact of Staphylococcus aureus infection in New York City hospitals
2. Staphylococcus aureus infections
3. Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus
4. Alpha-toxin and γ-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis
5. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model
6. Specific roles of α-toxin and β-toxin during Staphylococcus aureus corneal infection
7. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence
8. Molecular interactions between two global regulators, sar and agr, in Staphylococcus aureus
9. The sae locus of Staphylococcus aureus encodes a two-component regulatory system
10. Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus
11. Shift-down in growth rate rather than high cell density induces toxic shock syndrome toxin-1 gene expression in Staphylococcus aureus
12. The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4
13. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule
14. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus
15. Activation of α-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII
16. Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria
17. Autocrine regulation of toxin synthesis by Staphylococcus aureus
18. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus
19. Activation and inhibition of the staphylococcal agr system. Response
20. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone
21. Bacterial interference caused by autoinducing peptide variants
22. Activation and inhibition of the staphylococcal agr system. Technical comment
23. The agr P2 operon; an autocatalytic sensory transduction system in Staphylococcus aureus
24. The molecular architecture of the sar locus in Staphylococcus aureus
25. Osteomyelitis
26. Osteomyelitis
27. Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections
28. Methicillin-resistant Staphylococcus aureus septic arthritis; urgent and emergent
29. Bacteria associated with clinical mastitis in dairy heifers
30. Ulcerative keratitis. Survey of 30 years' laboratory experience
31. Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis
32. Alpha-toxin and γ-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis
33. Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus
34. Frequency of α- and β-haemolysin in Staphylococcus aureus of bovine and human origin. A comparison between pheno- and genotype and variation in phenotypic expression
35. Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus
36. Corneal virulence of Staphylococcus aureus; roles of α-toxin and protein A in pathogenesis
37. Histopathological studies of staphylococcal α-toxin; effects on rabbit corneas
38. Hypervariable epitope constructs (HECs) representing variability in gp130 of SIV induce a broad humoral immune response in rabbits and rhesus macaques
39. Experimental Staphylococcus aureus arthritis in mice
40. Antibiotic treatment of experimental S. aureus infections of the bovine mammary gland
41. Immunopathological features of rat Staphylococcus aureus arthritis
42. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice
43. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991
44. Methicillin-resistant Staphylococcus aureus septic arthritis; urgent and emergent
45. Development of penicillin resistance among Staphylococcus aureus isolated from bovine mastitis in Denmark and other countries
46. Characteristics of Staphylococcus aureus from subclinical bovine mastitis in Brazil
47. Pharmacokinetic considerations in the treatment of bacterial keratitis
48. Six years of surgical wound infection surveillance at a tertiary care center; review of the microbiologic and epidemiological aspects of wounds
49. Bacteremia associated with tunneled, cuffed hemodialysis catheters
50. Post-functional endoscopic sinus surgery methicillin-resistant Staphylococcus aureus sinusitis
51. New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection
52. Quorum sensing and the cell-cell communication dependent regulation of gene expression in pathogenic and non-pathogenic bacteria